These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7152425)

  • 21. Selective stimulation of renal PGE2 by potassium canrenoate in essential hypertension.
    Castellani S; Scarti L; Masotti G; Del Rosso A; Chen JI; Neri Serneri GG
    Prog Clin Biol Res; 1989; 301():297-301. PubMed ID: 2678128
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effect of spironolactone and K-canrenoate in ascitic cirrhosis. Double-blind study].
    Tempini S; Bellati G; Ideo G
    Minerva Dietol Gastroenterol; 1984; 30(3):255-61. PubMed ID: 6504374
    [No Abstract]   [Full Text] [Related]  

  • 23. Spironolactone and potassium canrenoate in normal man.
    Ramsay L; Shelton J; Harrison I; Tidd M; Asbury M
    Clin Pharmacol Ther; 1976 Aug; 20(2):167-77. PubMed ID: 780038
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative effects of canrenoate-K and prorenoate-K upon aldosterone biosynthesis in perifused frog interrenal glands.
    Delarue C; Leboulenger F; Tonon MC; Jegou S; Leroux P; Kusmierek MC; Corvol P; Vaillant R; Vaudry H
    Steroids; 1979 Sep; 34(3):319-32. PubMed ID: 494369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of a spirolactone derivative, sodium canrenoate, on mechanical and electrical activities of isolated rat myocardium.
    Coraboeuf E; Deroubaix E
    J Pharmacol Exp Ther; 1974 Oct; 191(1):128-38. PubMed ID: 4418463
    [No Abstract]   [Full Text] [Related]  

  • 26. The influence of intravenous canrenoate on the determination of digoxin in serum by radio- and enzyme-immunoassay.
    Lichey J; Rietbrock N; Borner K
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):61-3. PubMed ID: 370036
    [No Abstract]   [Full Text] [Related]  

  • 27. [Changes in aldosterone and PRA due to the administration of potassium canrenoate in laparotomized patients with liver cirrhosis].
    Ikebe H; Hoashi S; Irie F; Taniguchi K; Honda N; Mitarai Y; Kobayashi N
    Masui; 1988 May; 37(5):546-51. PubMed ID: 3045361
    [No Abstract]   [Full Text] [Related]  

  • 28. Chemical structure and aldosterone receptor affinity of canrenoate-potassium metabolites in rabbits.
    Finn AM; Finn C; Sadée W
    Res Commun Chem Pathol Pharmacol; 1976 Dec; 15(4):613-25. PubMed ID: 1005910
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Potassium canreonate in neurosurgical brain edema].
    Mille T; Rodriguez R; Baena Y
    Minerva Chir; 1975 Jul 15-31; 30(13-14):781-9. PubMed ID: 1221307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetics of spironolactone, canrenone and canrenoate-K in humans.
    Sadée W; Dagcioglu M; Schröder R
    J Pharmacol Exp Ther; 1973 Jun; 185(3):686-95. PubMed ID: 4712657
    [No Abstract]   [Full Text] [Related]  

  • 31. Aldosterone plasma radioimmunoassay interference by a spirolactone metabolite.
    Sadée W; Finn AM; Schmiedek P; Baethmann A
    Steroids; 1975 Mar; 25(3):301-11. PubMed ID: 1145668
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antagonism of aldosterone in normal subjects by Ro 12-2503 and spironolactone.
    Dux S; Rosenfeld J; Cocco G; Chu D; Gasser DF
    Arzneimittelforschung; 1982; 32(2):164-9. PubMed ID: 7199923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
    Gross ND; Kempton JB; Trune DR
    Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aldosterone antagonists. 3. Synthesis and activities of steroidal 7 alpha-(alkoxycarbonyl)-15,16-methylene spirolactones.
    Nickisch K; Bittler D; Laurent H; Losert W; Nishino Y; Schillinger E; Wiechert R
    J Med Chem; 1990 Feb; 33(2):509-13. PubMed ID: 2299621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Action of spironolactone and potassium canrenoate].
    Zaun H
    Hautarzt; 1990 Dec; 41(12):700. PubMed ID: 2089031
    [No Abstract]   [Full Text] [Related]  

  • 36. Potassium canrenoate, an aldosterone receptor antagonist, reduces isoprenaline-induced cardiac fibrosis in the rat.
    Bos R; Mougenot N; Médiani O; Vanhoutte PM; Lechat P
    J Pharmacol Exp Ther; 2004 Jun; 309(3):1160-6. PubMed ID: 14764658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aldosterone blunts human baroreflex sensitivity by a nongenomic mechanism.
    Schmidt BM; Horisberger K; Feuring M; Schultz A; Wehling M
    Exp Clin Endocrinol Diabetes; 2005 May; 113(5):252-6. PubMed ID: 15926109
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of aldosterone and anticonvulsant drugs on electroencephalographic and clinical disturbances induced by the spirolactone derivative, potassium canrenoate.
    Mertin J; Simon O; Schmiedek P
    J Neurol Sci; 1975 Jan; 24(1):13-20. PubMed ID: 1110371
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of aldosterone on the expression of plasminogen activator inhibitor-1 in renal mesangial cells: experiment with rat renal mesangial cells].
    Yuan J; Jia RH; Bao Y
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(34):2439-42. PubMed ID: 18036328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aldosterone receptor blockade inhibits increased furosemide-sensitive sodium reabsorption in rats with liver cirrhosis.
    Jonassen TE; Petersen JS; Sørensen AM; Andreasen F; Christensen S
    J Pharmacol Exp Ther; 1998 Dec; 287(3):931-6. PubMed ID: 9864275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.